Tag Archives: Covance

← Older posts

WI Watchlist: Amazon, JCI, Understory, Titan Spine, Eurofins

[Updated 11/28/18, 10:08 am. See below.] Time to catch up on recent headlines from Wisconsin’s innovation community: —Understory, a Madison-based startup that tracks weather via networks of solar-powered sensors, said it reeled in a $7.5 million investment led by local venture firm 4490 Ventures. Other investors in the deal included the Rise of the Rest […]

Posted in National blog main, Wisconsin, Wisconsin blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on WI Watchlist: Amazon, JCI, Understory, Titan Spine, Eurofins

Emulate’s “Organ-on-a-Chip” Tech Picked for FDA Research Partnership

[Updated 4/11/17, 9:44 a.m. See below.] Experimental drugs encounter their earliest tests in petri dishes and animals, but these tests can fall short of predicting what happens in humans. The life sciences industry has been pursuing what many hope is a better way: packing human cells into tiny chips developed as stand-ins for organs. This […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, New York blog main, Raleigh-Durham blog main | Tagged , , , , , , , , , , , , , , , , , , , , , | Comments Off on Emulate’s “Organ-on-a-Chip” Tech Picked for FDA Research Partnership

Raleigh-Durham Roundup: Quintiles, BDSI, BioCryst, & More

Here are the headlines from the last week in North Carolina biotech news. —Pharmaceutical services provider Quintiles (NYSE: Q) is teaming up with lab testing company Quest Diagnostics (NYSE: DGX) to provide clinical trial laboratory services around the world. Durham, NC-based Quintiles will own 60 percent of the joint venture while Quest will own the […]

Posted in National blog main, Raleigh-Durham, Raleigh-Durham blog main, Raleigh-Durham top stories | Tagged , , , , , , , , , , , , , , , , | Comments Off on Raleigh-Durham Roundup: Quintiles, BDSI, BioCryst, & More

Raleigh-Durham Roundup: LabCorp, Alevo, Piedmont Pharma, & More

Here are the headlines from the past week in North Carolina tech, biotech, and cleantech news. —LabCorp completed its $6.2 billion acquisition of Covance. Burlington, NC-based LabCorp (NYSE:LH), announced last November an agreement to acquire New Jersey-based Covance, a provider of outsourced services to the pharmaceutical industry. LabCorp, a laboratory testing and diagnostics company, says […]

Posted in National blog main, Raleigh-Durham, Raleigh-Durham blog main | Tagged , , , , , , , , , , , , , , , , | Comments Off on Raleigh-Durham Roundup: LabCorp, Alevo, Piedmont Pharma, & More

Raleigh-Durham Roundup: LabCorp, SignalShare, UNC, & More

Here are the week’s headlines in North Carolina tech and biotech news: —LabCorp (NYSE: LH) priced a $2.9 billion offering of senior notes to raise money to cover some costs related to its $6.1 billion acquisition of contract research organization Covance (NYSE: CVD). Burlington, NC-based LabCorp, a laboratory testing and diagnostics company, announced its deal […]

Posted in National blog main, Raleigh-Durham, Raleigh-Durham blog main | Tagged , , , , , , , , , , , , , , , | Comments Off on Raleigh-Durham Roundup: LabCorp, SignalShare, UNC, & More

Raleigh-Durham Roundup: LabCorp, UNC, HQ Greensboro, & More

Here are the week’s headlines in North Carolina tech and biotech news: —Diagnostics and laboratory testing company LabCorp (NYSE: LH) is expanding its DNA testing capabilities by acquiring Bode Technology. Burlington, NC-based LabCorp disclosed no financial terms for its purchase of Bode Technology from SolutionPoint International. Bode Technology specializes in forensic DNA analysis, proprietary DNA […]

Posted in National blog main, Raleigh-Durham, Raleigh-Durham blog main, Raleigh-Durham top stories | Tagged , , , , , , , , , , , , | Comments Off on Raleigh-Durham Roundup: LabCorp, UNC, HQ Greensboro, & More

LabCorp to Expand Drug Research Reach with $6.1B Deal for Covance

LabCorp (NYSE: LH), already one of the largest laboratory testing and diagnostics companies in the nation, plans to further expand its reach into clinical trials by buying contract research organization Covance (NYSE: CVD) in a deal valued at approximately $6.1 billion. The Burlington, NC, company will pay $105.12 per share in cash and stock to […]

Posted in National blog main, New York blog main, Raleigh-Durham, Raleigh-Durham blog main, Raleigh-Durham top stories, Wisconsin blog main | Tagged , , , , , , , , , , | Comments Off on LabCorp to Expand Drug Research Reach with $6.1B Deal for Covance

The Wisconsin Biotech Story: Slow and Steady Wins the Race

[Updated 1:04 pm PT] They say you can’t go home again. But sometimes you can go home after a few years and notice that your home has changed quite a bit. This past week, I went back to Wisconsin, where I’m originally from, to visit family and do some reporting. I stopped by the capitol, […]

Posted in Boston blog main, Detroit blog main, Detroit top stories, National blog main, National top stories, New York blog main, New York top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Wisconsin, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on The Wisconsin Biotech Story: Slow and Steady Wins the Race

Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 1)

John Lechleiter has spent his entire 32-year career at Eli Lilly, and now he’s the CEO just as the company faces one of the bigger challenges in its history. Over a three-year stretch, Lilly will lose patent protection on five blockbuster drugs that generated $12.7 billion in sales last year—more than half of its revenues. […]

Posted in Boston blog main, Detroit blog main, National, National blog main, New York blog main, San Diego blog main, San Francisco blog main, Seattle blog main | Tagged , , , , , , , , , , | 5 Comments

Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News

There’s been a deluge of venture capital news over the past week, and a flash flood of VC cash during the second quarter went mostly to San Diego’s life sciences sector. Our briefing begins now. —San Diego venture firms invested a total of $198.2 million in 29 local startups during the second quarter that ended […]

Posted in National blog main, San Diego, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News← Older posts